Literature DB >> 8320421

Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?

D Giugliano1, A Quatraro, A Minei, N De Rosa, L Coppola, F D'Onofrio.   

Abstract

Peripheral hyperinsulinism is said to be associated and perhaps implicated in the pathogenesis of hypertension. There is however some inconsistency in the evidence of the relationship between insulin and blood pressure. We prospectively investigated glucose metabolism, insulin and C-peptide values and serum lipids in a large sample of hypertensive as compared with age and body habitus-matched normotensive subjects. As a group, the 145 hypertensives (blood pressure: 160/99 +/- 8.5/6.5 mmHg, mean +/- SD) had significantly elevated fasting plasma insulin (p < 0.02), total and LDL-cholesterol (p < 0.01) than 132 normotensive control subjects. The fasting HbA1c (glycated hemoglobin A1c)/insulin ratio, an estimate of insulin sensitivity, was significantly lower (5.15 +/- 1.45) in the hypertensives than normotensives (5.8 +/- 1.5, p < 0.001). Hypertensives had normal fasting C-peptide levels and lower C-peptide/insulin molar ratios, indicating low hepatic insulin extraction. There was no correlation between mean blood pressure (1/3 systolic + 2/3 diastolic) and fasting serum C-peptide (p = 0.14), insulin (p = 0.11), HbA1c/insulin ratio (p = 0.6), C-peptide/insulin ratio (p = 0.22) and HbA1c (p = 0.19), even after adjusting for age, BMI and family history of diabetes. The differences between hypertensives and normotensives persisted after dividing the subjects according to the presence/absence of either obesity or impaired glucose tolerance, but the significance was lost due to the smaller samples of the subgroups. The obese hypertensives with impaired glucose tolerance had the lowest values of insulin sensitivity and clearance in the fasting state.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320421     DOI: 10.1007/BF03348843

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Overweight and mortality in Mexican Americans.

Authors:  M P Stern; J K Patterson; B D Mitchell; S M Haffner; H P Hazuda
Journal:  Int J Obes       Date:  1990-07

2.  Decreased insulin clearance as a feature of essential hypertension.

Authors:  T Salvatore; D Cozzolino; R Giunta; D Giugliano; R Torella; F D'Onofrio
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

3.  Serum-insulin in essential hypertension and in peripheral vascular disease.

Authors:  T A Welborn; A Breckenridge; A H Rubinstein; C T Dollery; T R Fraser
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

Review 4.  Current approaches to measurement of insulin secretion.

Authors:  K S Polonsky; A H Rubenstein
Journal:  Diabetes Metab Rev       Date:  1986

5.  Epidemiology of coronary heart disease: the Framingham study.

Authors:  W P Castelli
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

6.  Impaired glucose metabolism and reduced insulin clearance in elderly hypertensives.

Authors:  D Giugliano; T Salvatore; G Paolisso; R Buoninconti; R Torella; M Varricchio; F D'Onofrio
Journal:  Am J Hypertens       Date:  1992-06       Impact factor: 2.689

7.  Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

Authors:  P Ferrari; P Weidmann; S Shaw; D Giachino; W Riesen; Y Allemann; G Heynen
Journal:  Am J Med       Date:  1991-12       Impact factor: 4.965

8.  Blood pressure, insulin, and glycemia in nondiabetic subjects.

Authors:  A M Fournier; M T Gadia; D B Kubrusly; J S Skyler; J M Sosenko
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

9.  Retinopathy in older type II diabetics. Association with glucose control.

Authors:  D M Nathan; D E Singer; J E Godine; C H Harrington; L C Perlmuter
Journal:  Diabetes       Date:  1986-07       Impact factor: 9.461

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  4 in total

1.  Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data.

Authors:  Roberto Burattini; Micaela Morettini; Francesco Di Nardo; Massimo Boemi
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

2.  Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study.

Authors:  C C Lee; C Lorenzo; S M Haffner; L E Wagenknecht; M O Goodarzi; D Stefanovski; J M Norris; M J Rewers; A J Hanley
Journal:  Diabetes Obes Metab       Date:  2013-01-21       Impact factor: 6.577

3.  Insulin resistance and autonomic function in traumatic lower limb amputees.

Authors:  E Peles; S Akselrod; D S Goldstein; H Nitzan; M Azaria; S Almog; D Dolphin; H Halkin; M Modan
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

Review 4.  Regulation of Insulin Clearance by Non-Esterified Fatty Acids.

Authors:  Sonia M Najjar; Raziyeh Abdolahipour; Hilda E Ghadieh; Marziyeh Salehi Jahromi; John A Najjar; Basil A M Abuamreh; Sobia Zaidi; Sivarajan Kumarasamy; Harrison T Muturi
Journal:  Biomedicines       Date:  2022-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.